ES2192265T3 - Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente. - Google Patents

Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.

Info

Publication number
ES2192265T3
ES2192265T3 ES97911402T ES97911402T ES2192265T3 ES 2192265 T3 ES2192265 T3 ES 2192265T3 ES 97911402 T ES97911402 T ES 97911402T ES 97911402 T ES97911402 T ES 97911402T ES 2192265 T3 ES2192265 T3 ES 2192265T3
Authority
ES
Spain
Prior art keywords
flavor
dosage form
pharmaceutical dosage
masks
released quickly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97911402T
Other languages
English (en)
Inventor
Akinori Itoh
Toshiyuki Niwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2192265T3 publication Critical patent/ES2192265T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SUMINISTRA UNA FORMA DE DOSIFICACION FARMACEUTICA DE LIBERACION RAPIDA Y CON ENMASCARAMIENTO DEL SABOR QUE COMPRENDE UN NUCLEO QUE CONTIENE UN INGREDIENTE FARMACOLOGICAMENTE ACTIVO, CELULOSA DE HIDROXIPROPILO DE BAJA SUSTITUCION Y CELULOSA MICROCRISTALINA, LA CANTIDAD DE CELULOSA MICROCRISTALINA ES DE AL MENOS UN 26,0% DEL PESO EN BASE AL PESO TOTAL DEL NUCLEO; UNA CAPAZ DE REVESTIMIENTO INTERNA FORMADA SOBRE EL NUCLEO Y QUE CONTIENE UN POLIMERO SOLUBLE EN AGUA; Y UNA CAPA DE REVESTIMIENTO EXTERNA FORMADA SOBRE LA CAPA DE REVESTIMIENTO INTERNA Y QUE CONTIENE UN POLIMERO INSOLUBLE EN LAS SALIVA. TAMBIEN SE PRESENTA UN PROCEDIMIENTO PARA PREPARAR LA FORMA DE DOSIFICACION ORAL.
ES97911402T 1997-01-06 1997-11-20 Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente. Expired - Lifetime ES2192265T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9700003 1997-01-06

Publications (1)

Publication Number Publication Date
ES2192265T3 true ES2192265T3 (es) 2003-10-01

Family

ID=11004515

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97911402T Expired - Lifetime ES2192265T3 (es) 1997-01-06 1997-11-20 Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.

Country Status (36)

Country Link
EP (1) EP0941075B1 (es)
JP (1) JP3350059B2 (es)
KR (1) KR20000069899A (es)
CN (1) CN1244119A (es)
AP (1) AP802A (es)
AR (1) AR008553A1 (es)
AT (1) ATE238776T1 (es)
AU (1) AU715867B2 (es)
BG (1) BG103541A (es)
BR (1) BR9714253A (es)
CA (1) CA2277017C (es)
CO (1) CO4650099A1 (es)
DE (1) DE69721559T2 (es)
DK (1) DK0941075T3 (es)
EA (1) EA199900521A1 (es)
ES (1) ES2192265T3 (es)
HN (1) HN1997000151A (es)
HR (1) HRP980005A2 (es)
HU (1) HUP0002744A3 (es)
ID (1) ID21806A (es)
IL (1) IL130582A0 (es)
IS (1) IS5095A (es)
MA (1) MA26464A1 (es)
NO (1) NO993315L (es)
NZ (1) NZ336251A (es)
OA (1) OA11072A (es)
PA (1) PA8443301A1 (es)
PE (1) PE27999A1 (es)
PL (1) PL334439A1 (es)
SK (1) SK89599A3 (es)
TN (1) TNSN98002A1 (es)
TR (1) TR199901564T2 (es)
UY (1) UY24835A1 (es)
WO (1) WO1998030209A1 (es)
YU (1) YU31599A (es)
ZA (1) ZA9829B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
UA67802C2 (uk) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
EP2260836B1 (en) * 1998-11-25 2016-08-10 Cima Labs Inc. Rapid release tablet with coated drug-containing core and surrounding taste masking layer
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
ATE552013T1 (de) 2000-09-06 2012-04-15 Mitsubishi Tanabe Pharma Corp Zubereitungen zur oralen anwendung
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
GB2380936B (en) * 2001-10-18 2003-07-09 Reckitt Benckiser Healthcare Improvements in or relating to compositions
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
MXPA06010908A (es) 2004-03-25 2006-12-15 Astellas Pharma Inc Composicion para la preparacion farmaceutica solida de solifenacina o una sal de la misma.
BG66010B1 (bg) * 2004-12-08 2010-10-29 "Софарма" Ад Лекарствена форма на силденафил
DE602006020642D1 (de) * 2005-01-06 2011-04-21 Cima Labs Inc Geschmacksunterdrückungssystem für nicht weichgemachte Arzneimittel
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
WO2007010930A1 (ja) * 2005-07-20 2007-01-25 Astellas Pharma Inc. 口腔内崩壊製剤用の薬物含有被覆微粒子及びその製造方法
JP2007031407A (ja) 2005-07-29 2007-02-08 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
JP4602949B2 (ja) * 2006-08-02 2010-12-22 和光堂株式会社 被覆粒子含有組成物及びその製造方法
ES2441999T5 (es) * 2006-11-14 2018-01-23 Sunstar Inc. Composición oral que contiene celulosa cristalina tratada en su superficie con una sustancia soluble en agua
JP5777273B2 (ja) * 2008-07-10 2015-09-09 大正製薬株式会社 不快な呈味を有する薬物を含有する製剤粒子
JP4706785B2 (ja) * 2008-09-30 2011-06-22 アステラス製薬株式会社 経口投与用粒子状医薬組成物
EP2374460A4 (en) 2008-12-12 2013-08-21 Rhein Siegfried Sa De Cv SILDENAFIL COMPOSITION WITH PULSED RELEASE AND METHOD FOR PRODUCING THIS COMPOSITION
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
JP5933268B2 (ja) * 2009-12-28 2016-06-08 ニプロ株式会社 品質が向上した経口剤
JP5226732B2 (ja) * 2010-05-20 2013-07-03 エスエス製薬株式会社 催眠用圧縮成型製剤
TWI462739B (zh) * 2010-11-02 2014-12-01 Univ Kaohsiung Medical Ｓｉｌｄｅｎａｆｉｌ－同族物四級銨哌嗪鹽類之製備及醫療用途
GB201119985D0 (en) * 2011-11-19 2012-01-04 Diurnal Ltd Treatment of adrenal insufficiency
CN103271940B (zh) * 2013-05-03 2014-03-12 湖北新济药业有限公司 复方金属离子补充剂及其制备方法
EP3421032A4 (en) * 2016-02-23 2019-10-23 Nipro Corporation PARTICULARS OF A PHARMACEUTICAL COMPOSITION, ORAL DECOMPOSITION PREPARATION THEREOF AND METHOD FOR PRODUCING PARTICLES OF A PHARMACEUTICAL COMPOSITION
JP7837673B2 (ja) * 2018-08-28 2026-03-31 東和薬品株式会社 薬物含有粒子
CN113559070B (zh) * 2021-08-18 2022-12-06 广州中冠动物药业有限公司 一种适用于宠物咳嗽的药物制备方法
CN116139088B (zh) * 2023-01-31 2024-04-16 南京海纳医药科技股份有限公司 一种含有枸橼酸西地那非的干混悬剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
EP0458751A1 (en) * 1990-05-25 1991-11-27 Warner-Lambert Company Delivery system for cyclic amino acids with improved taste, texture and compressibility
JP2576927B2 (ja) * 1992-05-15 1997-01-29 ファイザー製薬株式会社 細粒核
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I

Also Published As

Publication number Publication date
AU4880897A (en) 1998-08-03
BG103541A (en) 2000-03-31
CO4650099A1 (es) 1998-09-03
IL130582A0 (en) 2000-06-01
BR9714253A (pt) 2000-04-18
DE69721559T2 (de) 2003-11-27
HRP980005A2 (en) 1998-10-31
CN1244119A (zh) 2000-02-09
HUP0002744A3 (en) 2001-01-29
PA8443301A1 (es) 2000-05-24
NO993315D0 (no) 1999-07-05
HUP0002744A2 (hu) 2000-12-28
AR008553A1 (es) 2000-01-19
ZA9829B (en) 1999-07-05
OA11072A (en) 2002-02-27
CA2277017C (en) 2002-11-26
YU31599A (sh) 2000-03-21
EA199900521A1 (ru) 1999-12-29
ATE238776T1 (de) 2003-05-15
KR20000069899A (ko) 2000-11-25
EP0941075B1 (en) 2003-05-02
AU715867B2 (en) 2000-02-10
ID21806A (id) 1999-07-29
EP0941075A1 (en) 1999-09-15
JP2000514830A (ja) 2000-11-07
NO993315L (no) 1999-07-05
DE69721559D1 (de) 2003-06-05
SK89599A3 (en) 2000-12-11
JP3350059B2 (ja) 2002-11-25
AP9801173A0 (en) 1998-01-31
UY24835A1 (es) 2000-09-29
HN1997000151A (es) 1997-12-20
WO1998030209A1 (en) 1998-07-16
AP802A (en) 2000-01-21
TR199901564T2 (xx) 1999-09-21
CA2277017A1 (en) 1998-07-16
MA26464A1 (fr) 2004-12-20
PE27999A1 (es) 1999-03-12
TNSN98002A1 (fr) 2005-03-15
PL334439A1 (en) 2000-02-28
DK0941075T3 (da) 2003-07-14
IS5095A (is) 1999-06-25
NZ336251A (en) 2001-01-26

Similar Documents

Publication Publication Date Title
AR008553A1 (es) Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
BR0115965A (pt) Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
HUP9900457A2 (hu) Eljárás, készítmények és kellékkészlet gyógyszerhatóanyagok orális biológiai hasznosulásának a növelésére
ID27504A (id) Formulasi oral baru
AR027158A1 (es) Forma de dosificacion oral para ser suministrada al estomago, dicha forma de dosificacion comprende una cantidad segura y efectiva de un ingrediente activo y excipientes farmacologicamente aceptables
UY25544A1 (es) Forma de dosificación de nefazodona
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
BR0113331A (pt) Derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica
BRPI0513300A (pt) forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
TR199800894T2 (xx) Biyo-yap��kan kat� dozaj formlar�.
ATE374601T1 (de) Multipartikuläre arzneiform, enthaltend mucoadhaesiv formulierte peptid- oder protein- wirkstoffe, sowie ein verfahren zur herstellung der arzneiform
SV1999000152A (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
AR014012A1 (es) Formula de liberacion prolongada
ES2191987T3 (es) Formas de dosificacion de ribavirina solidas, administrables oralmente, y procedimiento de fabricacion.
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
BR0114100A (pt) Formulações de liberação controlada para administração oral
AR087240A2 (es) Composiciones farmaceuticas que tienen epinastina y pseudoefedrina
HN2001000038A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
CO5210867A1 (es) Formulacion farmaceutica oral solida de liberacion controlada de rivastigmina con revestimiento que comprende dos peliculas
HRP20020258B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
BR0012822A (pt) Formulação farmacêutica, e, forma de dosagem em tablete